
    
      Randomized clinical trial performed in woman with epithelial primary ovarian cancer (stage
      FIGO II, III and IV) or tumor recurrence. A cytoreductive surgery will be perform in all of
      the patients include in the trial, and it will be assign at randomization:

        -  HIPEC-arm: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with
           paclitaxel (175 mg / m2) for 60 minutes at a temperature of 42-43ยบ degrees; followed by
           postoperative systemic IV chemotherapy with carboplatin (AUC=6) and paclitaxel (175
           mg/m2) for 6 cycles.

        -  No HIPEC-arm: Cytoreductive surgery followed by postoperative systemic IV chemotherapy
           with carboplatin (AUC=6) and paclitaxel (175 mg/m2) for 6 cycles.
    
  